Spinraza has been proven to stop the progression of spinal muscular atrophy, a disease that deteriorates a person's muscles until they can’t breath. Each dose of the drug costs $125,000 and six doses are needed in the first year alone.

The drug would help sufferers of the rare, debilitating disease reverse its degenerative effects on the body. But 'Spinraza'--as it's called, also comes with a hefty price tag.

CBC's Chris Glover is talking back to the studio when one man leans into the frame behind him.

Colleges and universities critic Chris Glover says he is deeply concerned that Ontario Student Assistance Plan grants will be cut.

The schools have until Jan. 1, 2019 to develop, implement and comply with the policies, which experts said were aimed at pleasing a segment of the Tory base that was outraged when some speakers and professors came under fire for their conservative views.